White matter hyperintensities and cortical acetylcholinesterase activity in parkinsonian dementia

Acta Neurologica Scandinavica

Volumn 113, Issue 2, 2006, Pages 87-91

  Marshall, G A ^a,b   Shchelchkov, E ^a   Kaufer, D I ^c   Ivanco, L S ^a   Bohnen, N I ^a,d  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Acetylcholinesterase activity; Magnetic resonance imaging; Parkinsonian dementia; Positron emission tomography; White matter hyperintensities

Indexed keywords

ACETYLCHOLINESTERASE; CARBON 11; METHYL 4 PIPERIDINYL PROPIONATE; PIPERIDINE DERIVATIVE; PROPIONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; HUMAN; HYDROLYSIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSONISM; POSITRON EMISSION TOMOGRAPHY; QUANTITATIVE ANALYSIS; RATING SCALE; WHITE MATTER;

ACETYLCHOLINESTERASE; AGED; CASE-CONTROL STUDIES; CEREBRAL CORTEX; DEMENTIA; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PARKINSONIAN DISORDERS; SEVERITY OF ILLNESS INDEX;

EID: 33645312948     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2005.00553.x     Document Type: Article

References (27)

1. B ohnen NI K aufer DI I vanco L et al. Cortical cholinergic function is more severely affected in Parkinsonian dementia than in Alzheimer's Disease: an in vivo PET study Arch Neurol 2003 60 1745 8
2. R uberg M P loska A J avoy -A gid F A gid Y Muscarinic binding and choline acetyltransferase activity in Parkinsonian subjects with reference to dementia Brain Res 1982 232 129 39
3. C andy JM P erry RH P erry EK et al. Pathological changes in the nucleus of Meynert in Alzheimer's and Parkinson's diseases J Neurol Sci 1983 59 277 89
4. W hitehouse PJ H edreen JC W hite CL III. P rice DL Basal forebrain neurons in the dementia of Parkinson disease Ann Neurol 1983 13 243 8
5. P erry EK C urtis M D ick DJ et al. Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease J Neurol Neurosurg Psychiatry 1985 48 413 21
6. M attila PM R oytta M L onnberg P M arjamaki P H elenius H R inne JO Choline acetytransferase activity and striatal dopamine receptors in Parkinson's disease in relation to cognitive impairment Acta Neuropathol (Berl) 2001 102 160 6
7. B urn DJ M c K eith IG Current treatment of dementia with Lewy bodies and dementia associated with Parkinson's disease Mov Disord 2003 18 S72 9
8. B uee L H of PR B ouras C et al. Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders Acta Neuropathol (Berl) 1994 87 469 80
9. L ibon DJ B ogdanoff B L eopold N et al. Neuropsychological profiles associated with subcortical white matter alterations and Parkinson's disease: implications for the diagnosis of dementia Arch Clin Neuropsychol 2001 16 19 32
10. J ellinger KA Prevalence of cerebrovascular lesions in Parkinson's disease. A postmortem study Acta Neuropathol (Berl) 2003 105 415 9
11. E rkinjuntti T R oman G G authier S Treatment of vascular dementia-evidence from clinical trials with cholinesterase inhibitors Neurol Res 2004 26 603 5
12. R oman GC Cholinergic dysfunction in vascular dementia Curr Psychiatry Rep 2005 7 18 26
13. R oman GC Rivastigmine for subcortical vascular dementia Expert Rev Neurother 2005 5 309 13
14. N amba H I yo M F ukushi K et al. Human cerebral acetylcholinesterase activity measured with positron emission tomography: procedure, normal values and effect of age Eur J Nucl Med 1999 26 135 43
15. M c K eith IG P erry EK P erry RH Report of the second dementia with Lewy body international workshop. Diagnosis and treatment Neurology 1999 53 902 5
16. T alairach J T ournoux P Co-planar stereotaxic atlas of the human brain: 3-dimensional proportional system: an approach to medical cerebral imaging Stuttgart, New York Thieme Medical Publishers 1988
17. I rie T F ukushi K A kimoto Y T amagami H N ozaki T Design and evaluation of radioactive acetylcholine analogs for mapping brain acetylcholinesterase (AChE) in vivo Nucl Med Biol 1994 21 801 8
18. 11C]PMP) for in vivo measurements of acetylcholinesterase activity Nucl Med Biol 1998 25 751 4
19. W iseman M N ichols T W oods R S weeney J M intun M Stereotaxic techniques comparing foci intensity and location of activation areas in the brain as obtained using positron emission tomography (PET) J Nucl Med 1995 36 93P
20. B ohnen NI K aufer DI H endrickson R et al. Degree of inhibition of cortical acetylcholinesterase activity and cognitive effects by donepezil treatment in Alzheimer's disease J Neurol Neurosurg Psychiatry 2005 76 315 9
21. 11C]methylpiperidin-4-yl propionate: alternatives for analysis of an irreversible positron emission tomography tracer for measurement of acetylcholinesterase activity in human brain J Cereb Blood Flow Metab 1999 19 1150 63
22. S cheltens P B arkhof F L eys D et al. A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging J Neurol Sci 1993 114 7 12
23. S elden NR G itelman DR S alamon -M urayama N P arrish TB M esulam MM Trajectories of cholinergic pathways within the cerebral hemispheres of the human brain Brain 1998 121 2249 57
24. H eckers S G eula C M esulam MM Acetylcholinesterase-rich pyramidal neurons in Alzheimer's disease Neurobiol Aging 1992 13 455 60
25. O 'Brien JT W iseman R B urton EJ et al. Cognitive associations of subcortical white matter lesions in older people Ann N Y Acad Sci 2002 977 436 44
26. S ultzer DL M ahler ME C ummings JL V an G orp WG H inkin CH B rown C Cortical abnormalities associated with subcortical lesions in vascular dementia. Clinical and position emission tomographic findings Arch Neurol 1995 52 773 80
27. W olfe N L inn R B abikian VL K noefel JE A lbert ML Frontal systems impairment following multiple lacunar infarcts Arch Neurol 1990 47 129 32